Empower your cancer research with proteomics
Scalable and validated platform for biomarker discovery
Did you know?
Olink’s Proximity Extension Assay (PEA) technology
for protein biomarker discovery has been cited in
over 160 peer-reviewed publications in the fields of
oncology and cancer immunotherapy.
Ryan Sullivan, MD
Associate Director, Melanoma Program Mass General Cancer Center; Associate Professor, Harvard Medical School
Russell W. Jenkins, MD, PhD,
Assistant Professor, Harvard Medical School; Faculty Member, Center for Cancer Research; Associate Member, Broad Institute of MIT and Harvard
A benchtop system for protein biomarker analysis
Olink® Signature Q100
Olink Signature Q100 is a user-friendly instrument for readout of all Olink® Flex, Target and Focus protein biomarker panels. Olink Flex, combined with Olink Signature Q100, gives you an efficient workflow with robust performance. There is no need for time-consuming washing steps that could cause loss of material. Learn more about this benchtop solution and how to streamline your protein biomarker analysis.
Flexibility without compromise
Introducing Olink® Flex
Olink’s highly flexible made-to-order product, Olink® Flex, enables you to select and combine targets for up to 21 human proteins in one biomarker panel
Protein data points generated
Publications listed on website